Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news snapshot: Kromek, ITM Power, Rockfire Resources

A glance at some of the day's highlights from the Proactive Investors newswire

Kromek Group PLC (LON:KMK) is expecting to hit its targets for the latest full year and said it was “well-placed” to capitalise on opportunities going forward.

ITM Power PLC (LON:ITM) has extended its contract with Shell for the company’s hydrogen-based vehicle refueling collaboration. A new agreement replaces a 2015 deal and extends the contract out to 2024.

Rockfire Resources PLC (LON:ROCK) has added another 1km to the length of the potential gold strike at Double Event in Queensland, Australia.

ImmuPharma PLC (LON:IMM) has confirmed it remains in negotiations with potential corporate partners for its lead drug Lupuzor, which has been developed to treat the auto-immune disease lupus.

A Spanish foods giant has signed a licensing agreement to use OptiBiotix Health PLC’s (LON:OPTI) cholesterol and blood pressure-reducing LPLDL strain in some of its products.

Ariana Resources PLC (LON:AAU) has revealed latest drill results from the Kiziltepe mine, in the Arzu North area, and, they show potential for a large-tonnage system. Highlight results include grades up to 1.5 grams per tonne gold and 17.5 grams per tonne silver.

Motif Bio PLC (LON:MTFB, NASDAQ:MTFB) is expected to be able to chart a “path forward” for its lead drug iclaprim in the next month after a meeting with the US regulator went ahead as planned.

Live Company Group Plc (LON:LVCG) together with its German partner AWC, has attended the Touring Exhibitions Meeting in Berlin. BP Mar

Premier African Minerals PLC (LON:PREM) has signed an agreement with Zimbabwe’s indigenisation agency [NIEFF] that will see the RHA tungsten mine re-open without any additional funding from the miner.

Faron Pharmaceuticals Ltd (LON:FARN) boss Markku Jalkanen has told investors “there is definitely a future” for the company’s Traumakine treatment.

ADES International Holding PLC (LON:ADES) told investors it has expanded its credit facilities with Alinma Bank, a Saudi Arabia based financial institution.

Graphene specialist Directa Plus PLC (LON:DCTA) and clothing group Alfredo Grassi have extended their exclusive relationship for up to a further three years.

Arecor Limited has dosed the first patient in a trial of its ultra-rapid acting insulin product, AT247.

Early-stage research has shown that Allergy Therapeutics PLC’s (LON:AGY) adjuvant technology could potentially be used in the fight against cancer.

Thor Mining PLC (LON:THR)(ASX:THR) has revealed further interim exploration results from drilling at the Bonya tungsten deposits, adjacent Molyhil, in the Northern Territory of Australia. Interim results for the Samarkand prospect obtained via portable X-ray fluorescence (XRF) determination show highlights of 15 metres grading 0.44% tungsten trioxide (WO₃), 8 metres at 0.36% WO₃, and 11 metres at 0.61% WO₃.

Greatland Gold PLC (LON:GGP) has started a field exploration campaign at its Black Hills licence in Western Australia while also announcing plans for a maiden drilling programme at the site.

Natural resources investor Metal Tiger PLC (LON:MTR) has set out the upcoming exploration programme for its portfolio of assets in the Kalahari copper belt in Botswana.

Midatech Pharma PLC (LON MTPH) (NASDAQ: MTP) chief executive Craig Cook is to present at an investor evening hosted by the company's new retail broker Turner Pope Investments, on May 13 in London.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK